Evidence map›Paper›PMID 20543113›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation.

Natalia V Giltiay, Yi Lu, David Allman, Trine N Jørgensen, Xiaoxia Li

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Function of Act1 in IL-17 family signaling and autoimmunity.Advances in experimental medicine and biology · 2012
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Natalia V GiltiayDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Yi Lu
David Allman
Trine N Jørgensen
Xiaoxia Li
Cleveland Clinic Lerner College of Medicine · USUniversity of Pennsylvania · US

Funding

Act1 in CD40-/BAFFR-Mediated B Cell SurvivalR01AI065470 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, XIAOXIA · 2005 to 2009
$1.8M
NIAID NIH HHS R01 AI065470
6 · The paper itself

Abstract

The transitional stage is a key check-point for elimination of autoreactive B cells in the periphery. This selection process requires fine regulation of signals received through BCR and B cell activating factor (BAFF) receptor. We previously identified the adaptor molecule Act1 as a negative regulator of BAFF-mediated signaling. Deficiency of Act1 in mice results in peripheral B cell hyperplasia and development of autoimmunity. In this study, we demonstrate that Act1 plays a critical role in the regulation of transitional B cell survival and maturation. We found that the ratio of late-transitional (T2) to early-transitional (T1) cells was increased in spleens from Act1-deficient mice. Moreover, BAFF stimulation induced better T1 cell survival and promoted more efficient maturation of T1 cells into T2 cells ex vivo in the absence of Act1. BAFF stimulation induced higher levels of the anti-apoptotic Bcl-2 member Mc1-l in Act1-deficient T1 cells than in wild-type control cells, suggesting that Mcl-1 might be one of the key effector molecules for BAFF-mediated survival of the Act1-deficient transitional B cells. Importantly, costimulation with BAFF was able to rescue Act1-deficient T1 cells from BCR-induced apoptosis more effectively than Act1-sufficient T1 B cells. Finally, by using hen egg lysozyme double transgenic mice, we demonstrated that Act1 deficiency can promote the maturation of Ag-specific autoreactive B cells. Taken together, our results suggest that the transitional stage is a critical point of action of Act1 in the elimination of autoreactive B cells and in the regulation of peripheral B cell homeostasis.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsB-Cell Activating FactorB-Lymphocyte SubsetsCell DifferentiationCells, CulturedCell SurvivalHomeostasisLymphopeniaMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, TransgenicMuramidaseAdaptor Proteins, Signal TransducingB-Cell Activating Factorhen egg lysozymeMuramidaseTnfsf13b protein, mouseTraf3ip2 protein, mouse

Identifiers

PMID20543113
PMCPMC3225255
OpenAlexW1538039325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.